PharmaSwiss Hellas S.A.

Valeant based in Montreal, Canada, employs 17,000 employees worldwide and is listed at the New York and Toronto stock exchanges under the VRX ticker. Valeant is ranked as No 14th in the pharmaceutical companies’ listings, with market capitalization of over $ 80 billion, and a clear goal to be in the top five by 2020!

The company’s development strategy is to acquire, develop and market new products through strategic partnerships, and to expand its product line by adding new formulations or products through company or product acquisitions.

Valeant Pharmaceuticals International Inc, is a multinational specialty pharma company that develops and promotes prescription and non-prescription medicinal products that really make a difference in the lives of patients and in therapeutic areas such as dermatology, ophthalmology, neurology, branded generics and OTC products.

PharmaSwiss Hellas SA (a Valeant Group company) was established in Greece in 2005 posing a strong presence in the prescription of medicines, OTC & Pharmacy products, medical devices and parts of interventional and non-interventional dermatology and cosmetology and a leading role in the Ophthalmology sector. It employs 65 employees in total. Mr. Iakovos Michalitsis is the Regional General Manager of Valeant (PharmaSwiss) for Greece, Cyprus and Malta.

Address:
53, Pentelis Ave., 152 35 Vrilissia, Greece

Telephone:
210-8108460

Fax:
210-8108480

Website:
http://www.pharmaswiss.com
http://www.valeant.com